Labopharm
Navigation Links
Labopharm in Medical News
Labopharm Reports Results for Second Quarter Fiscal 2009
...- LAVAL, QC, Aug. 7 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today reported it...ward-Tripp, President and Chief Executive Officer, labopharm Inc. "We are encouraged by a number of aspects sin...hat RYZOLT was just recently launched in May 2009, labopharm is recording its royalty earned for the quarter ba...Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
... LAVAL, QC, July 30 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced t...entation will be available for 30 days. About labopharm Inc. labopharm is an emerging leader in optimizing the performanc...Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
...- LAVAL, QC, July 27 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced t...discuss its second quarter 2009 financial results. labopharm will report its second quarter 2009 financial resu...ived at the above web site for 30 days. About labopharm Inc. ...Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
... LAVAL, QC, July 20 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced i...ed. The API manufacturer, Angelini, has informed labopharm that, further to the FDA's complete response lette...ward-Tripp, President and Chief Executive Officer, labopharm Inc. "We continue to prepare for the commercializa...Labopharm amends debt facility agreement with Hercules
...- LAVAL, QC, June 25 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced i...able repayment terms. Under the amended agreement, labopharm has extended the date required to begin repaying t.... In consideration of the revised repayment terms, labopharm will not draw down the remaining US$5 million of t......- LAVAL, QC, May 19 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced t...dy to Appear at Scientific Meeting in Florida labopharm will present a poster discussing the results of th... User Fee Act (PDUFA) is July 18, 2009. About labopharm Inc. ...
New Once-Daily RYZOLT(TM) (tramadol HCl extended-release tablets) Now Available in the U.S.
...December 31, 2010(1). RYZOLT was developed by labopharm Inc. (Nasdaq: DDSS ; TSX: DDS) of Canada and app... be found at www.purduepharma.com . About labopharm Inc. labopharm is an emerging leader in optimizing the performanc...Labopharm Reports Results for First Quarter Fiscal 2009
.... - LAVAL, QC, May 7 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today reported it...ward-Tripp, President and Chief Executive Officer, labopharm Inc. "With Ryzolt(TM), U.S. physicians now have a ...ing Partnerships for Eleven Additional Countries - labopharm signed an agreement with iNova Pharmaceuticals, it...Labopharm announces details for first quarter results conference call and annual meeting
... LAVAL, QC, April 23 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced t...nce Call On Thursday, May 7 at 8:30 a.m. (ET) labopharm will host a conference call to discuss its first quarter 2009 financial results. labopharm will report its first quarter 2009 financial resul...Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
... LAVAL, QC, April 2 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced t... and demonstration of efficacy in clinical trials. labopharm believes that it is likely that the results of thi...o severe pain in the rest of the world. About labopharm Inc. ...Labopharm in Medical Technology
Labopharm files New Drug Submission with Health Canada for novel antidepressant
... LAVAL, QC, Aug. 5 /PRNewswire-FirstCall/ - labopharm Inc. (TSX: DDS; NASDAQ: DDSS ) today announced i...ward-Tripp, President and Chief Executive Officer, labopharm Inc. "We believe the $800 million-plus Canadian ma...depression at some time in their lives. About labopharm Inc. ......lowing are the top five drugs in each category of phase changes: The Five Most Promising Drugs Entering Phase III Trials - trazodone, (Depression), labopharm - pimavanserin, (Schizophrenia), ACADIA Pharmaceuticals - salmon calcitonin, (Osteoporosis/Paget's disease), Novartis/Nordic Bioscience - Generx...
... LAVAL, QC, June 29, 2007 /PRNewswire-FirstCall/ - labopharm Inc. today announced that it will present a poster...ward-Tripp, President and Chief Executive Officer, labopharm Inc. "The ability to quickly titrate patients to t...s of Labopharm's drug optimization technologies. labopharm also announced today that an article discussing th...
Other TagsPHASPHASPHASPHASPHASPHASVAMPHSVHSVOther Contentscolostrumcolostrumcolposcopycomedocompartmentcompartmentcompartmentcompartmentcompartmentcompartmentcomedonescomacomacomacomacompulsioncompulsioncommunicablecommunicablecommunicable
(Date:11/30/2009).... 30 Kemin Foods, L.C. ("Kemin") a...tive Health Technologies, Ltd. ("OmniActive") have...The parties agree that Kemin,s US Patent No. 5,382...tion, Purification and Recrystallization of Lutein...of" and the reissues of that patent are valid and ...
(Date:11/30/2009)...ov. 30 American Diversif...eased to announce the appointment of Howard M. Mc...y,s Board of Directors. Mr. McEldowney, whose inve... at the Chemical Bank in New York City and subsequ...McEldowney, San Francisco, an institutional money ...
(Date:11/30/2009)..., PHILADELPHIA, Pennsylvania, November 30 /P...ates From Elsevier,s Top Thought Leaders Provide I..., Elsevier, a world leader in healthcare publ...tronic health record (EHR) integrated solutions, t...erican Recovery and Reinvestment,Act (ARRA) update...
(Date:11/30/2009)...ntrol and Prevention estimate that well over one m...th HIV/AIDS. New research from North Carolina Stat... minorities and do not have health insurance, and ...ilitate education and prevention efforts in minori...hich analyzed 90,000 HIV patient hospital visits o...
(Date:11/30/2009)...tal has launched a series of clinical trials in or...atment. This approach involves the application of ...mour cells from the patient him or herself and des...ressive and frequent malignant tumours. The new th...mbined with the standard, first-line treatment inv...
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 2Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 3Health News:Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog 4Health News:Research highlights need for national HIV strategy 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6[0] OmniActive and Kemin Reach Amicable Settlement in Patent Dispute[0] American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company[0] Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog[0] Research highlights need for national HIV strategy[0] Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
(Date:11/30/2009)...called invasion proteins are crucial for infection... human cells, which stimulates the host cell to ta...ules exert a different function, for example the r...oup,s results have now been published in the curre..., Spoiled meat is one of the sources for Lister...
(Date:11/30/2009)... obstacle to HIV research is the virus,s exquisite...cientists, traditional tools, like the humble lab ...a team of researchers writing in BioMed Central,s ...nious assault on this problem by creating a mouse ...ng infected with HIV. , George Kassiotis, from t...
(Date:11/30/2009)... , VILNIUS, Lithuania, Nov. 30 /PRNewswire/...om ), a provider of high-precision biometric ident...des in the company,s core product line: VeriLook ...ognition and MegaMatcher 3.1 SDK for large-scale...ication systems (AFIS). Expanded capabilities in V...
Breaking Biology News(10 mins):It takes 2 to infect 2A reductionist approach to HIV research 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3Liver Cancer Patients May Get Hope 59093 1Liver Cancer Patients May Get Hope 59093 2Potential Pieces of Autism Puzzle Revealed 59089 1Potential Pieces of Autism Puzzle Revealed 59089 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 1BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |